Výsledky vyhľadávania - "Glucosides/adverse effects [MeSH]"

Safety of Empagliflozin: An Individual Participant-Level Data Meta-Analysis from Four Large Trials

Autori: Christoph Wanner Hristo Iliev Nathalia Duarte a ďalší

Zdroj: Adv Ther

Predmety: Male, Heart Failure, ddc:610, Middle Aged, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Randomized Controlled Trials as Topic [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Adverse drug event, Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Original Research, SGLT2 inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Adverse drug reaction, Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Drug safety, Cardiovascular Diseases [MeSH], Heart Failure [MeSH], Middle Aged [MeSH], Renal Insufficiency, Chronic [MeSH], Glucosides/therapeutic use [MeSH], Empagliflozin, Glucosides, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Humans, Hypoglycemic Agents, Female, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Randomized Controlled Trials as Topic

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38771475
https://repository.publisso.de/resource/frl:6508947
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-398088
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39808
https://doi.org/10.1007/s12325-024-02879-w
https://opus.bibliothek.uni-wuerzburg.de/files/39808/12325_2024_Article_2879.pdf

Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY

Autori: Masaomi Nangaku William G. Herrington Shinya Goto a ďalší

Zdroj: Clin Exp Nephrol

Predmety: Male, Kidney, 01 natural sciences, 03 medical and health sciences, 0302 clinical medicine, Glucosides, Japan, Double-Blind Method, Humans, Albuminuria, Renal Insufficiency, Chronic, Benzhydryl Compounds, 0101 mathematics, Sodium-Glucose Transporter 2 Inhibitors, Aged, Middle Aged, 16. Peace & justice, 3. Good health, Treatment Outcome, Cardiovascular Diseases, Disease Progression, Benzhydryl Compounds/therapeutic use [MeSH], Double-Blind Method [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Renal Insufficiency, Chronic/physiopathology [MeSH], Disease Progression [MeSH], Renal Insufficiency, Chronic/diagnosis [MeSH], Aged [MeSH], Cardiovascular disease, Kidney/physiopathology [MeSH], Male [MeSH], Glucosides/adverse effects [MeSH], Glomerular Filtration Rate/drug effects [MeSH], Kidney Failure, Chronic/drug therapy [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Humans [MeSH], Albuminuria/drug therapy [MeSH], Treatment Outcome [MeSH], Cardiovascular Diseases [MeSH], Middle Aged [MeSH], Japan/epidemiology [MeSH], Glucosides/therapeutic use [MeSH], Kidney function, Rapid Communication, Randomised trial, Sodium–glucose co-transporter-2 inhibitor, Renal Insufficiency, Chronic/drug therapy [MeSH], Kidney Failure, Chronic, Female, Glomerular Filtration Rate

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38643286
https://repository.publisso.de/resource/frl:6505774

Lebensbedrohliche euglykämische Ketoacidose unter Therapie mit Empagliflozin beim kardiochirurgischen Patienten: seltener Einzelfall oder zukünftig ein häufiges Problem?

Autori: Wachter, H. von Loeffelholz, C. Thomas-Rüddel, D. O. a ďalší

Zdroj: Anaesthesiologie

Predmety: Kasuistiken, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Cardiac Surgical Procedures/adverse effects [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Ketosis/chemically induced [MeSH], Postoperative Complications/drug therapy [MeSH], Aged [MeSH], Humans [MeSH], Glucosides/therapeutic use [MeSH], Male [MeSH], Glucosides/adverse effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH]

Prístupová URL adresa: https://repository.publisso.de/resource/frl:6522254

Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial

Autori: Fitchett, David Zinman, Bernard Inzucchi, Silvio E. a ďalší

Zdroj: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-7 (2024)

Predmety: Male, Time Factors, Myocardial Infarction, Risk Assessment, 03 medical and health sciences, Diabetes mellitus, 0302 clinical medicine, Glucosides, Risk Factors, Recurrence, Sodium-glucose transporter 2 inhibitors, Diseases of the circulatory (Cardiovascular) system, Humans, Myocardial infarction, Type 2, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, Research, Middle Aged, 3. Good health, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Risk Assessment [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Risk Factors [MeSH], Diabetes Mellitus, Type 2/mortality [MeSH], Male [MeSH], Myocardial Infarction/diagnosis [MeSH], Glucosides/adverse effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Myocardial Infarction/mortality [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Myocardial Infarction/prevention, Humans [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Recurrence [MeSH], Myocardial Infarction/epidemiology [MeSH], Glucosides/therapeutic use [MeSH], Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, Female

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38992713
https://doaj.org/article/e033bb1ddc7949bca3ef1b0df0c3d965
https://cardiab.biomedcentral.com/articles/10.1186/s12933-024-02328-6
https://doi.org/10.1186/s12933-024-02328-6
https://repository.publisso.de/resource/frl:6509802

Is GFR decline induced by SGLT2 inhibitor of clinical importance?

Autori: Günes-Altan, Merve Bosch, Agnes Striepe, Kristina a ďalší

Zdroj: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)

Predmety: Male, Time Factors, Linagliptin, Pulse Wave Analysis, Kidney, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Glucosides, Diseases of the circulatory (Cardiovascular) system, Humans, Insulin, Diabetic Nephropathies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, PWV, Research, Middle Aged, Metformin, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, GFR decline, Female, Drug Therapy, Combination, Benzhydryl Compounds/therapeutic use [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Diabetes Mellitus, Type 2/physiopathology [MeSH], Sodium-Glucose Transporter 2 [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Metformin/therapeutic use [MeSH], Kidney/physiopathology [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Clinical Relevance [MeSH], Drug Therapy, Combination [MeSH], SGLT2 inhibitors, Glomerular Filtration Rate/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Insulin [MeSH], Linagliptin/adverse effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Diabetic Nephropathies/drug therapy [MeSH], Pulse Wave Analysis [MeSH], Vascular Stiffness/drug effects [MeSH], Glomerular Filtration Rate

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38811998
https://doaj.org/article/16e1093b68244e548ee9caeec43f6782
https://repository.publisso.de/resource/frl:6506955

Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure

Autori: Agnes Bosch Susanne Jung Julie Kolwelter a ďalší

Zdroj: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)

Predmety: Male, Time Factors, Blood Pressure, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Double-Blind Method, Glucosides, Germany, Diseases of the circulatory (Cardiovascular) system, Humans, ddc:610, Prospective Studies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Original Investigation, Aged, Benzhydryl Compounds/therapeutic use [MeSH], Double-Blind Method [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Angiology, Up-Regulation [MeSH], 3-Hydroxybutyric Acid/blood [MeSH], Male [MeSH], Chronic Disease [MeSH], Cardiology, Glucosides/adverse effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Heart Failure/drug therapy [MeSH], Heart Failure/physiopathology [MeSH], Humans [MeSH], Prospective Studies [MeSH], Blood Pressure/drug effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetes, Glucosides/therapeutic use [MeSH], Germany [MeSH], Vascular Stiffness/drug effects [MeSH], Heart Failure/blood [MeSH], Heart Failure/diagnosis [MeSH], Heart Failure, 3-Hydroxybutyric Acid, Middle Aged, Up-Regulation, 3. Good health, Treatment Outcome, RC666-701, Chronic Disease, Female, Biomarkers

Popis súboru: application/pdf

Prístupová URL adresa: https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-021-01410-7
https://pubmed.ncbi.nlm.nih.gov/34753480
https://doaj.org/article/b7b30358f28b414ca7ef3d20f55fd8c2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579532
https://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01410-7
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/18119
https://repository.publisso.de/resource/frl:6462947

Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine

Autori: Manuel Korn Agnes Bosch Dennis Kannenkeril a ďalší

Zdroj: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-8 (2021)

Predmety: Male, Renal Plasma Flow, Insulin Glargine, Linagliptin, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Type 2 diabetes, Renal, Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Insulin Glargine/adverse effects [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Hemodynamics/drug effects [MeSH], Dipeptidyl-Peptidase IV Inhibitors/therapeutic use [MeSH], Metformin/therapeutic use [MeSH], Original Investigation, Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Metformin/adverse effects [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Drug Therapy, Combination [MeSH], Glomerular Filtration Rate/drug effects [MeSH], Diabetic Nephropathies/prevention, Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Diabetic Nephropathies/etiology [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Intraglomerular, Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Linagliptin/adverse effects [MeSH], Prospective Studies [MeSH], Renal Plasma Flow/drug effects [MeSH], Insulin Glargine/therapeutic use [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Hemodynamics, Germany [MeSH], Dipeptidyl-Peptidase IV Inhibitors/adverse effects [MeSH], 03 medical and health sciences, 0302 clinical medicine, Glucosides, Germany, Diseases of the circulatory (Cardiovascular) system, Humans, Hypoglycemic Agents, Diabetic Nephropathies, ddc:610, Prospective Studies, Benzhydryl Compounds, Aged, Dipeptidyl-Peptidase IV Inhibitors, Middle Aged, Metformin, 3. Good health, Diabetes Mellitus, Type 2, RC666-701, Drug Therapy, Combination, Female, Glomerular Filtration Rate

Popis súboru: application/pdf

Prístupová URL adresa: https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-021-01358-8
https://pubmed.ncbi.nlm.nih.gov/34481498
https://doaj.org/article/9b8533fc41d14d86a46ea53eb65ce82e
https://link.springer.com/article/10.1186/s12933-021-01358-8
https://link.springer.com/content/pdf/10.1186/s12933-021-01358-8.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418746/
https://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01358-8
https://opus4.kobv.de/opus4-fau/files/18118/s12933-021-01358-8.pdf
https://repository.publisso.de/resource/frl:6462949

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study

Autori: Rau, Matthias Thiele, Kirsten Hartmann, Niels-Ulrik Korbinian a ďalší

Zdroj: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Cardiovascular diabetology 20(1), 6 (2021). doi:10.1186/s12933-020-01175-5

Predmety: Male, Diastolic function, Time Factors, Pilot Projects, Hemodynamic parameters, 03 medical and health sciences, Patient Admission, 0302 clinical medicine, Double-Blind Method, Glucosides, Germany, Diseases of the circulatory (Cardiovascular) system, Humans, Prospective Studies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Original Investigation, Aged, Heart Failure, 2. Zero hunger, Diabetes, Stroke Volume, Recovery of Function, Middle Aged, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Cardiovascular Diseases/drug therapy [MeSH], Benzhydryl Compounds/therapeutic use [MeSH], Double-Blind Method [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Stroke Volume/drug effects [MeSH], Aged [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Ventricular Pressure/drug effects [MeSH], Male [MeSH], Glucosides/adverse effects [MeSH], SGLT2 inhibitors, Cardiovascular Diseases/physiopathology [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Recovery of Function [MeSH], Heart Failure/drug therapy [MeSH], Heart Failure/physiopathology [MeSH], Humans [MeSH], Prospective Studies [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Glucosides/therapeutic use [MeSH], Cardiovascular Diseases/diagnostic imaging [MeSH], Germany [MeSH], Pilot Projects [MeSH], Ventricular Function, Left/drug effects [MeSH], Vascular Resistance/drug effects [MeSH], Patient Admission [MeSH], RC666-701, Female

Prístupová URL adresa: https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-020-01175-5
https://pubmed.ncbi.nlm.nih.gov/33413355
https://doaj.org/article/0bfafb3ebec549339276a1d59e86beeb
https://link.springer.com/article/10.1186/s12933-020-01175-5
https://pubmed.ncbi.nlm.nih.gov/33413355/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791833
https://cardiab.biomedcentral.com/articles/10.1186/s12933-020-01175-5
https://www.scilit.net/article/33349ed51fe4e54b8697be37f7c822e4?action=show-references
https://www.researchsquare.com/article/rs-45927/v2
https://repository.publisso.de/resource/frl:6463289
https://publications.rwth-aachen.de/record/851226